CharlesEdwardMillerMD

Obstetrics & Gynecology • Naperville, IL

Reproductive Endocrinology & Infertility

Associate Clinical Professor of Obstetrics & Gynecology, University Chicago-Pritzker School of Medicine

Join to view full profile

Dr. Miller is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Miller's full profile

Already have an account?

Office
120 Osler Drive
Suite 100
Naperville, IL 60540
Phone+1 630-428-2229

Fax+1 630-428-0336

Education & Training

University of Pennsylvania Health SystemResidency, Obstetrics and Gynecology, 1982 - 1983
University of Texas Southwestern Medical CenterResidency, Obstetrics and Gynecology, 1978 - 1980
University of Texas Southwestern Medical Center/Parkland Memorial HospitalInternship, Transitional Year, 1977 - 1978
Northwestern University The Feinberg School of MedicineClass of 1977

Certifications & Licensure

IL State Medical License 1983 - 2026
NY State Medical License 1997 - 2026
TX State Medical License 1979 - 2026
PA State Medical License 1981 - 1984
American Board of Obstetrics and Gynecology Obstetrics & Gynecology

Awards, Honors, & Recognition

Super Doctor SuperDoctors.com
Top MD Consumers Checkbook
Fellow (FACOG) American Congress of Obstetricians and Gynecologists

Clinical Trials

Clinical Evaluation of the Interlace Medical Hysteroscopic Morcellator Start of enrollment: 2009 Feb 01
Completed
a Study to Evaluate Adhesion Risk in Fertility Patients' Status Post Laparoscopic Myomectomy. Start of enrollment: 2013 Aug 01
Withdrawn
Not Applicable
Safety & Effectiveness Study of AEGEA Vapor System to Treat Excessive Uterine Bleeding Start of enrollment: 2014 Feb 01
Unknown status
Phase 3
Power Morcellation Systems for Laparoscopic Hysterectomy and Myomectomy Start of enrollment: 2016 May 01
Completed
Not Applicable
A Study to Investigate Efficacy and Safety of OG-6219 BID in 3 Dose Levels Compared With Placebo in Participants Aged 18 to 49 With Moderate to Severe Endometriosis-related Pain Start of enrollment: 2022 Oct 25
Recruiting
Phase 2
Roles: Principal Investigator, Contact
Join now to see all

Publications & Presentations

PubMed

1 citations
Efficacy, tolerability, and bone density outcomes of elagolix with add-back therapy for endometriosis-associated pain: twelve months of an ongoing randomized phase 3 t...
Charles E Miller, Jin Hee Kim, Robin Kroll, James A Simon, Ahmed M Soliman
American Journal of Obstetrics and Gynecology. 2024-12-01
2 citations
Hysteroscopic resection for management of early pregnancy loss: a case report and literature review.
Stacy Young, Charles E Miller
F&S Reports. 2022-06-01
14 citations
The Future of Adhesion Prophylaxis Trials in Abdominal Surgery: An Expert Global Consensus.
Rudy Leon De Wilde, Rajesh Devassy, Richard P G Ten Broek, Charles E Miller, Aizura Adlan
Journal of Clinical Medicine. 2022-03-08

Press Mentions

Elagolix Is Effective Second-Tier Treatment for Endometriosis-Associated DysmenorrheaNovember 22nd, 2019
Treating Uterine FibroidsSeptember 30th, 2019
The Ovarian Remnant SyndromeJuly 24th, 2019
Join now to see all

Professional Memberships